REVASC-PAD:田纳西大学医学中心外周动脉疾病限制性血管运动可行性研究 (REVASC-PAD)
The purpose of this study is to evaluate the effects of Blood Flow Restriction (BFR) training on walking function, health-related quality of life, and safety among adults with Peripheral Arterial Disease (PAD).
The main aims of the study are:
- Evaluate change in walking function among patients with PAD undergoing BFR training. The investigators will assess change in Six-Minute Walk Test (6MWT) distance from baseline to post-intervention and 3-month follow-up to compare functional improvements between the BFR group and the two control groups
- Assess changes in health-related quality of life among patients with PAD undergoing BFR training. The investigators will use the EuroQol 5-Dimension 5-Level (EQ-5D-5L) scale to evaluate quality-of-life changes from baseline to post-intervention and 3-month follow-up across all study arms
- Evaluate the safety and feasibility of a supervised BFR training program for patients with PAD. The investigators will compare adverse event (AE) and serious adverse event (SAE) rates across study arms, while also monitoring sessional ratings of perceived exertion (RPE), dyspnea, and claudication pain as indicators of symptom response and exercise tolerance. Feasibility will be assessed through enrollment success, intervention adherence, and retention rates across groups
研究概览
地位
条件
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Tiffany Johnson, Study Coordinator
- 电话号码:+1865-305-4682
- 邮箱:thjohnson@utmck.edu
学习地点
-
-
Tennessee
-
Knoxville、Tennessee、美国、37920
- 招聘中
- University of Tennessee Medical Center
-
首席研究员:
- Morgan Randall, MD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- 18 years of age or older
- Diagnosed peripheral arterial disease with stable claudication (symptomatic presentation unchanged for 6 months)
- Ankle-brachial index (ABI) between 0.4 and 0.9.
- Eligible referral to cardiovascular or pulmonary rehabilitation
- Prior revascularization permitted if symptoms are stable and other criteria are met
Exclusion Criteria:
- Recent change in resting ECG suggesting significant ischemia, recent myocardial infarction (within 2 weeks), or another acute cardiac event
- Unstable angina
- Uncontrolled cardiac arrhythmias
- Symptomatic severe aortic stenosis or other significant valvular disease
- Decompensated symptomatic heart failure
- Acute pulmonary embolism or infarction
- Acute noncardiac disorder likely to interfere with or be worsened by exercise (e.g., infection, thyrotoxicosis)
- Acute myocarditis or pericarditis
- Acute thrombophlebitis
- Physical disability precluding safe or adequate exercise performance
- Significant electrolyte abnormalities
- Clinically significant tachyarrhythmias or bradyarrhythmias
- High-degree atrioventricular block
- Atrial fibrillation with uncontrolled ventricular response
- Hypertrophic obstructive cardiomyopathy with resting left ventricular outflow gradient of >25 mmHg
- Known active aortic dissection
- Severe resting arterial hypertension (SBP>200mmHg or DBP >110 mmHg)
- Mental impairment preventing cooperation with study procedures
- Current pregnancy
- Moderate to severe peripheral neuropathy
- Open wounds or compromised skin near BFR cuff site
- Active DVT or thromboembolic event within the past year
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Blood Flow Restriction (BFR) Training
Participants perform supervised lower-body resistance training using pneumatic cuffs (Smart Cuff Pro or equivalent) applied to the proximal thighs. Cuffs are inflated to 60-80% of the participant's measured arterial occlusion pressure (AOP). Pressure is increased at Weeks 5 and 9 based on tolerance. Cuff inflation will not exceed 80% of limb occlusion pressure. Cuffs will be immediately deflated if participants' vitals suggest poor tolerance. |
All BFR resistance sessions will include two standardized lower-extremity exercises: seated calf raises and standing calf raises. Each session will follow this protocol:
|
|
有源比较器:Low-Load Traditional Resistance Training (LL-RT)
Participants perform the same two calf exercises (seated and standing calf raises) without BFR cuffs. If participants demonstrate the ability to complete all prescribed repetitions without undue strain, planned load progressions of approximately 5-10% 1RM will be introduced at Weeks 5 and 9. Repetitions and sets will remain fixed to match the BFR protocol. |
Two resistance exercises (seated and standing calf raises) using the same repetition structure
|
|
有源比较器:High-Load Traditional Resistance Training (HL-RT)
Participants in this group will perform seated and standing calf raises following a more conventional strength training model. Similar to the other groups, if participants can complete their prescribed workload without excessive strain, two planned load progressions (5-10% 1RM) will be applied at Weeks 5 and 9. Repetitions and sets will remain fixed to preserve consistency in training structure across groups. This group serves as a benchmark for conventional resistance training in clinical and musculoskeletal rehabilitation populations. |
Each session includes:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Walking Function
大体时间:Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)
|
Change in walking distance measured by the Six-Minute Walk Test (6MWT) from baseline to end of intervention and 3-month follow-up visit. |
Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)
|
|
Quality of Life (QoL) (1)
大体时间:Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)
|
Change in health-related quality of life as assessed by EuroQol 5-Dimension 5-Level (EQ-5D-5L) from baseline to post-intervention and 3-month follow-up |
Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)
|
|
Quality of Life (QoL) (2)
大体时间:Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)
|
Change in depressive symptoms as assessed by Patient Health Questionnaire-9 (PHQ-9) from baseline to post-intervention and 3-month follow-up |
Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)
|
|
Quality of Life (QoL) (3)
大体时间:Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)
|
Change in self-reported walking function and symptom burden assessed by using REVASC-PAD Walking Questionnaire from baseline to post-intervention and 3-month follow-up |
Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Claudication Onset Time (COT) during 6MWT
大体时间:Baseline, post-intervention (8 to 12 weeks), and 3 months post-intervention
|
Time to onset of claudication symptoms during 6MWT at baseline, post-intervention, and 3-month follow-up |
Baseline, post-intervention (8 to 12 weeks), and 3 months post-intervention
|
|
Ratings of Perceived Exertion (RPE), Dyspnea, and Claudication Pain
大体时间:Multiple assessments from Visit 2 through end of intervention (approximately 8 to 12 weeks)
|
Session-based self-reported symptom ratings collected at each supervised exercise session from Visit 2 to end of intervention (approximately 8 to 12 weeks). These ratings assess exercise tolerance and symptom burden during blood flow restriction training. |
Multiple assessments from Visit 2 through end of intervention (approximately 8 to 12 weeks)
|
|
Adverse Event (AE) and Serious Adverse Event (SAE) Rates
大体时间:Baseline to 3-month follow-up
|
Number and rate of adverse events and serious adverse events occurring during the study period. |
Baseline to 3-month follow-up
|
|
Enrollment, Retention, and Adherence Rates
大体时间:Baseline to 3-month follow-up
|
Rates of successful enrollment, participant retention at post-intervention and 3-month follow-up, and adherence to prescribed exercise sessions |
Baseline to 3-month follow-up
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.